| | | 68596 | | 07.07.2022 | | Labatec Pharma SA | | | | | | | 06.07.2027 | | | | | | | | | | 11.09. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Dorzolamide/Timolol Labatec 20.0 mg/ml, 5.0 mg/ml | collyre en solution | collyre en solution (Dorzolamide 20 mg/ml, Timolol 5 mg/ml) | S01ED51 | CI |
|
|
